Rafael Pharmaceuticals
Open
1 Duncan Dr
Cranbury, NJ 08512
Cornerstone Pharmaceuticals Inc. is engaged in developing innovative anti-metabolic cancer therapies, focusing on their lead drug candidate CPI-613 (devimistat). The company is currently testing this candidate in various combinations within preclinical cancer models.
Located in Monmouth Junction, New Jersey, Cornerstone Pharmaceuticals is dedicated to advancing research and development in the field of oncology. Their efforts aim to improve treatment options for patients battling cancer through novel therapeutic approaches.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Foursquare.